These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 3053205)
21. [A clinical evaluation of CA 125 levels in serum, ascites and pleural effusion]. Jibiki K; Demura R; Abe Y; Odagiri E; Demura H Gan No Rinsho; 1987 Nov; 33(14):1756-62. PubMed ID: 3480363 [TBL] [Abstract][Full Text] [Related]
22. Density distribution and immunological reactivity of tumor cells from peritoneal effusions of patients with ovarian neoplasms. Harłozińska A; Bar JK; Cisło M; Richter R; Rabczyński J Anal Cell Pathol; 1992 Jan; 4(1):1-12. PubMed ID: 1370907 [TBL] [Abstract][Full Text] [Related]
24. Patterns of reactivity of four novel monoclonal antibodies (B72.3, DF3, B1.1 and B6.2) with cells in human malignant and benign effusions. Szpak CA; Johnston WW; Lottich SC; Kufe D; Thor A; Schlom J Acta Cytol; 1984; 28(4):356-67. PubMed ID: 6205527 [TBL] [Abstract][Full Text] [Related]
25. HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma. Davidson B; Elstrand MB; McMaster MT; Berner A; Kurman RJ; Risberg B; Trope CG; Shih IeM Gynecol Oncol; 2005 Jan; 96(1):42-7. PubMed ID: 15589578 [TBL] [Abstract][Full Text] [Related]
26. A new epithelial membrane antigen (Calam 27) as a marker of carcinoma in serous effusions. Gioanni J; Caldani C; Zanghellini E; Mazeau C; Duplay H; Ferrua B; Schneider M Acta Cytol; 1991; 35(3):315-9. PubMed ID: 2042433 [TBL] [Abstract][Full Text] [Related]
27. Use of two epithelium-specific monoclonal antibodies for diagnosis of malignancy in serous effusions. Epenetos AA; Canti G; Taylor-Papadimitriou J; Curling M; Bodmer WF Lancet; 1982 Nov; 2(8306):1004-6. PubMed ID: 6127499 [TBL] [Abstract][Full Text] [Related]
28. Improvement of tumor cell detection using a pool of monoclonal antibodies. Tagliabue E; Porro G; Barbanti P; Della Torre G; Ménard S; Rilke F; Cerasoli S; Colnaghi MI Hybridoma; 1986; 5(2):107-15. PubMed ID: 2424821 [TBL] [Abstract][Full Text] [Related]
29. Autologous antibodies eluted from membrane fragments in human ovarian epithelial neoplastic effusions. II. Tissue specificity and reactivity. Kutteh WH; Doellgast GJ J Natl Cancer Inst; 1986 May; 76(5):797-804. PubMed ID: 3517453 [TBL] [Abstract][Full Text] [Related]
30. Use of MoAb D612 in combination with a panel of MoAb for the immunocytochemical identification of metastases from colon-rectum carcinoma. Mottolese M; Venturo I; Digiesi G; Perrone Donnorso R; Bigotti A; Muraro R; Aluffi A; Natali PG Br J Cancer; 1990 Apr; 61(4):626-30. PubMed ID: 2184879 [TBL] [Abstract][Full Text] [Related]
31. Immunocytochemical reaction of Ca1 and HMFG2 monoclonal antibodies with cells from serous effusions. Singer S; Boddington MM; Hudson EA J Clin Pathol; 1985 Feb; 38(2):180-4. PubMed ID: 3881482 [TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical markers in the identification of metastatic breast cancer. de Almeida PC; Pestana CB Breast Cancer Res Treat; 1992; 21(3):201-10. PubMed ID: 1325217 [TBL] [Abstract][Full Text] [Related]
33. Immunocytochemical identification of carcinomas of unknown primary in serous effusions. Pomjanski N; Grote HJ; Doganay P; Schmiemann V; Buckstegge B; Böcking A Diagn Cytopathol; 2005 Nov; 33(5):309-15. PubMed ID: 16240395 [TBL] [Abstract][Full Text] [Related]
34. [Prospective comparison of the diagnostic value of cytology and immunocytology in pleural effusion studied by thoracoscopy and biopsy]. Neubauer A; Thalmann U; Musch R; Grosser H; Loddenkemper R; Huhn D Klin Wochenschr; 1987 May; 65(9):400-6. PubMed ID: 3298829 [TBL] [Abstract][Full Text] [Related]
35. [Detection of gastric cancer associated antigens in ascitic and pleural fluid for ascertaining the nature of the exudate]. Zhang JR; Zhang XY; Chen XT Zhonghua Nei Ke Za Zhi; 1989 Dec; 28(12):729-30, 768. PubMed ID: 2636090 [TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical panel for distinguishing between carcinoma and reactive mesothelial cells in serious effusions. Lee JS; Nam JH; Lee MC; Park CS; Juhng SW Acta Cytol; 1996; 40(4):631-6. PubMed ID: 8693877 [TBL] [Abstract][Full Text] [Related]
37. Identification of adenocarcinoma in cytospin preparations of effusions using monoclonal antibody B72.3. Martin SE; Moshiri S; Thor A; Vilasi V; Chu EW; Schlom J Am J Clin Pathol; 1986 Jul; 86(1):10-8. PubMed ID: 3524191 [TBL] [Abstract][Full Text] [Related]
38. Carcinoma of ovarian and other origins in effusions. Immunocytochemical study with a panel of monoclonal antibodies. Flynn MK; Johnston W; Bigner S Acta Cytol; 1993; 37(4):439-47. PubMed ID: 8328236 [TBL] [Abstract][Full Text] [Related]
39. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters. Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270 [TBL] [Abstract][Full Text] [Related]
40. Identification of the primary site of metastatic adenocarcinoma in serous effusions. Value of an immunocytochemical panel added to the clinical arsenal. Longatto Filho A; Alves VA; Kanamura CT; Nonogaki S; Bortolan J; Lombardo V; Bisi H Acta Cytol; 2002; 46(4):651-8. PubMed ID: 12146025 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]